OcuMension, Immunotech Bio launch IPOs
OcuMension Therapeutics hit the market on Monday with its HK$1.55bn ($200m) IPO, the latest in a stream of healthcare sector listings on the city’s stock exchange.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: